[2]
World Health Organization, Human African Trypanosomiasis, Fact sheet N°259, updated January. 2017.
[4]
Huber, D.; Barrett, M.P. Uptake and mode of action of drugs used against sleeping sickness. Biochem. Pharmacol., 2001, 61, 1-5.
[5]
Kennedy, P.G.E. Human African trypanosomiasis of the CNS: Current issues and challenges. J. Clin. Invest., 2004, 113, 496-504.
[6]
Bhambra, A.S.; Edgar, M.; Elsegood, M.R.J.; Li, Y.; Weaver, G.W.; Arroo, R.R.J.; Yardley, V.; Burrell-Saward, H.; Krystof, V. Design, synthesis and antitrypanosomal activities of 2,6-disubstituted-4,5,7-trifluorobenzothiophenes. Eur. J. Med. Chem., 2016, 108, 347-353.
[7]
World Health Organization, Malaria, Fact sheet N°094, updated April. 2017.
[8]
Tun, K.M.; Imwong, M.; Lwin, K.M.; Win, A.A.; Hlaing, T.M.; Hlaing, T.; Lin, K.; Kyaw, M.P.; Plewes, K.; Faiz, M.A.; Dhorda, M.; Yeong, C.P.; Pukrittayakamee, S.; Ashley, E.A.; Anderson, T.J.C.; Nair, S.; McDew-White, M.; Flegg, J.A.; Grist, E.P.M.; Guerin, P.; Maude, R.J.; Smithuis, F.; Dondorp, A.M.; Day, N.P.J.; Nosten, F.; White, N.J.; Woodrow, C.J. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: A cross-sectional survey of the K13 molecular marker. Lancet Infect. Dis., 2015, 15, 415-421.
[9]
Lu, F.; Culleton, R.; Zhang, M.; Ramaprasad, A.; von Seidlein, L.; Zhou, H.; Zhu, G.; Tang, J.; Liu, Y.; Wang, W.; Cao, Y.; Xu, S.; Gu, Y.; Li, J.; Zhang, C.; Gao, Q.; Menard, D.; Pain, A.; Yang, H.; Zhang, Q.; Cao, J. emergence of indigenous artemisinin-resistant plasmodium falciparum in Africa. N. Engl. J. Med., 2017, 376, 991-993.
[10]
Faist, J.; Hinteregger, C.; Seebacher, W.; Saf, R.; Mäser, P.; Kaiser, M.; Weis, R. New derivatives of 7-chloroquinolin-4-amine with antiprotozoal activity. Bioorg. Med. Chem., 2017, 25, 941-948.
[11]
Hochegger, P.; Faist, J.; Seebacher, W.; Saf, R.; Mäser, P.; Kaiser, M.; Weis, R. New derivatives of quinoline-4-carboxylic acid with antiplasmodial activity. Bioorg. Med. Chem., 2017, 25, 2251-2259.
[12]
Pandey, S.; Agarwal, P.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Verma, P.; Saxena, J.K.; Sharma, A.; Lal, J.; Chauhan, P.M.S. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents. Eur. J. Med. Chem., 2013, 66, 69-81.
[13]
Ostrovskii, V.A. Medicinal chemistry of tetrazoles. Russ. Chem. Bull., 2012, 61, 768-780.
[14]
Nava-Zuazo, C.; Estrada-Soto, S.; Guerrero-Alvarez, J.; León-Rivera, I.; Molina-Salinas, G.M.; Said-Fernández, S.; Chan-Bacab, M.J.; Cedillo-Rivera, R.; Moo-Puc, R.; Mirón-López, G.; Navarrete-Vazquez, G. Design, synthesis, and in vitro antiprotozoal, antimycobacterial activities of N-2-[(7-chloroquinolin-4-yl)amino] ethylureas. Bioorg. Med. Chem., 2010, 18, 6398-6403.
[15]
Martin, R.E.; Green, L.G.; Guba, W.; Kratochwil, N.; Christ, A. Discovery of the first nonpeptidic, small-molecule, highly selective somatostatin receptor subtype 5 antagonists: A chemogenomics approach. J. Med. Chem., 2007, 50, 6291-6294.
[16]
Madrid, P.B.; Liou, A.P.; DeRisi, J.L.; Guy, R.K. Incorporation of an intramolecular hydrogen-bonding motif in the side chain of 4-aminoquinolines enhances activity against drug-resistant P. Falciparum. J. Med. Chem., 2006, 49, 4535-4543.
[17]
Baltz, T.; Baltz, D.; Giroud, C.; Crockett, J. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J., 1985, 4, 1273-1277.
[18]
Räz, B.; Iten, M.; Grether-Bühler, Y.; Kaminsky, R.; Brun, R. The Alamar blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop., 1997, 68, 139.
[19]
Huber, W.; Koella, J.C. A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop., 1993, 55, 257-261.
[20]
Desjardins, R.E.; Canfield, C.J.; Haynes, J.D.; Chulay, J.D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother., 1979, 16, 710-718.
[21]
Matile, H.; Pink, J.R.L. In: Immunological Methods; Lefkovits, I.; Pernis, B., Eds.; Academic Press: San Diego, 1990; pp. 221-234.
[22]
Ponnudurai, T.; Leeuwenberg, A.D.; Meuwissen, J.H. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop. Geogr. Med., 1981, 33, 50-54.
[23]
Thaithong, S.; Beale, G.H.; Chutmongkonkul, M. Susceptibility of Plasmodium falciparum to five drugs: An in vitro study of isolates mainly from Thailand. Trans. R. Soc. Trop. Med. Hyg., 1983, 77, 228-231.
[24]
Page, B.; Page, M.; Noel, C. A new fluorometric assay for cytotoxicity measurements in-vitro. Int. J. Oncol., 1993, 3, 473-476.
[25]
Ahmed, S.A.; Gogal, R.M.; Walsh, J.E. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J. Immunol. Methods, 1994, 170, 211-224.